Introduction
============

Bangladesh, with its subtropical weather and fertile deltaic land, is rich in a variety of medicinal plants. The traditional medicine system of Bangladesh has developed over generations through trial and error. Bangladesh is the habitat of more than 500 medicinal plant species and the rural people have long depended on them for their primary healthcare needs ([@B12]). Currently, about 250 medicinal plants are being used for the preparation of herbal formulations in Bangladesh and the estimated market value of medicinal plants is around 3.3 billion BDT (4.1 million USD) ([@B12]; [@B3]). The traditional healers of Bangladesh utilize these medicines of plant origin to treat various disease conditions including inflammation, hypertension, asthma, diabetes, gastro-intestinal disorders, cardiac problems, and skin diseases among different localities and communities throughout the country ([@B12]; [@B33],[@B34]; [@B16]; [@B15]).

*Chrysopogon aciculatus* (Retz.) Trin. of the Poaceae family is a vigorous creeping grass commonly growing in Bangladesh. Locally in Bangladesh, it is known as Premkata, Chorkata, Chui-kanta, and distributed all over the country. This tropical grassland species also grows in many other Asian countries including Malaysia, India, Nepal, Philippines, China and Indonesia, where it is commonly known as 'Love Grass'([@B11]). A study conducted in Nepal revealed that this grass species is a popular cattle feed constituting 45% of total grazed pasture in lowland areas ([@B23]). It is an exotic grass in Nigeria, where it is well established as a lawn grass ([@B38]). This medicinal herb plays an important ethnomedicinal role in different regions across the world and extensively used for the management of wide range of ailments. In lieu of diverse traditional uses, a few medicinal property of this weed has been evaluated and reported so far. In Bangladesh, the Garo ethnic community from Madhupur, Tangail uses *C. aciculatus* root juice to cure liver pain and the whole plant of *C. aciculatus* to treat cattle leg swelling, where it is known by the name Negraban and Negra bam ([@B2]). Investigations revealed *C. aciculatus* to be rich in biologically important phytoconstituents belonging to several chemical classes including glycosylflavones, flavonols, sterols, flavones and germacranolides (**Supplementary Table [S1](#SM1){ref-type="supplementary-material"}**).

As a part of our continuing research on medicinal plants of Bangladesh, present study was undertaken to evaluate the local ethnomedicinal use, the antinociceptive activity of the ethanolic extract of *C. aciculatus* on animal model and to identify bioactive phytoconstituents by chemical profiling through LC-MS and GC-MS ([@B30]; [@B36]; [@B44]). Analgesic activity was observed in both peripheral and central model of analgesia. Furthermore, computational study was conducted with the identified compounds against human COX-2 enzyme. The aim of this study was to draw a scientific basis to the traditional use of this plant in mitigating pain among the traditional healthcare practitioners of Bangladesh.

Materials and Methods {#s1}
=====================

Materials
---------

The plant *Chrysopogon aciculatus* (Retz.) Trin. (Family: Poaceae) was collected from Khulna University area, Gallamari, Khulna-9100, Bangladesh on April, 2014. The plant material was identified by the experts of Bangladesh National Herbarium, Bangladesh where a voucher specimen (DACB 45183) has been submitted for future reference. Reference drugs, Diclofenac sodium and Morphine, were generously provided by Beximco Pharmaceutical Ltd., Bangladesh and Popular Phamaceutical Ltd., Bangladesh, respectively.

Extraction
----------

Collected plant parts were separated from undesirable materials and were washed with water. Sun-dried plant material was ground to coarse powder with the help of a suitable grinder (Capacitor start motor, Wuhu motor factory, China). The powdered material was soaked in ethanol for 5 days with occasional shaking and stirring. The crude extract was obtained through filtration and evaporation of the solvent with the aid of a rotary evaporator.

Experimental Animals
--------------------

Young Swiss Albino mice, aging 4--5 weeks and weighing 25--28 g, were purchased from Animal Resources Branch of International Centre for Diarrhoeal Disease Research, Bangladesh (ICCDR,B). The animals were acclimatized with an ambient temperature of 25 ± 2 °C; 12 h dark-light cycle and 56--60 % relative humidity under pathogen free condition. Our study was approved by the Animal Ethics Committee, Pharmacy Discipline, Life Science School, Khulna University, Khulna-9208, Bangladesh (Protocol Number: KU/PHARM/AEC/15/006/025).

Identification of Phytochemical Constituents
--------------------------------------------

Presence of different classes of phytochemicals in the ethanol extract of *C. aciculatus* including reducing sugar, tannins, flavonoids, saponins, gums, steroids, alkaloids, glycosides, and terpenoids were investigated by standard procedures.

Acute Toxicity Test
-------------------

Test mice were randomly divided into control and test groups containing six mice of either sex in each group. Test groups were administered with graded doses (62.5--4000 mg/kg b.w., p.o.) of *C. aciculatus* extract while control group received vehicle (1% Tween 80 in water, p.o.). Then the animals were observed for 72 h for mortality and any sign of toxicity ([@B24]).

Acetic Acid Induced Writhing Test
---------------------------------

Animals of either sex were divided into negative control, positive control and test groups. Thirty min prior to the administration of acetic acid (0.7%, 10 ml/kg b.w., i.p.), control and positive control group were treated with vehicle (1% Tween 80 in water, p.o.) and standard diclofenac sodium (25 mg/kg b.w., p.o.) respectively, while the test groups received *C. aciculatus* extract at the doses of 500 and 750 mg/kg b.w. orally. After 5 min of administration of acetic acid the animals were observed for 10 min and the number of writhes by each group was recorded ([@B36]).

Hot Plate Test
--------------

Experimental animals were treated with control vehicle (1% Tween 80 in water, p.o.), morphine (5 mg/kg b.w., i.p.) and *C. aciculatus* extract (500 and 750 mg/kg b.w., p.o.). They were then placed onto a hot plate maintained at 55 ± 0.5°C to induce pain stimulus on each 30 min starting from the treatment throughout the observation period of 2 h. Response time i.e., time taken for paw licking or jumping was recorded as a measure of the analgesic effect of the treatment. A cut off time of 15 min was maintained to prevent any possible injury to the experimental animals ([@B36]).

LC-MS Analysis
--------------

LC-MS analysis was conducted using Agilent 6530 Accurate-Mass Q-TOF LC-MS system equipped with a C18 analytical column of 50 mm × 2.1 mm, 1.8 μm particle size (Agilent 6530). Column oven temperature of 35°C and flow rate of 250 μL/min were maintained throughout the experiment. Water and acetonitrile, each containing 5 mM ammonium formate and 0.1% formic acid, were used as mobile phase A and B, respectively. The injection volume was 20 μL with a run time of 15 min. The linear gradient program was set as follows: 0 min, 100% A; 0--45 min, 0--100% B; 46--50 min, 100% B; 51--55 min, 100% A. The UHPLC was hyphenated to a triple quadrupole mass spectrometer 3200 QTrap (ABSciex) equipped with an electrospray ionization interface set at negative mode. The interface heater held at the temperature of 500°C and an ion-spray (IS) voltage of -4500 eV. The nebulizing gas (GS1), heating gas (GS2) and curtain gas pressures set at 40, 40, and 10 psi, respectively during the whole analysis. Nitrogen was used as collision and spray gas. Full scan data acquisition was performed, scanning from *m/z* 5 to 1500 in enhanced MS IDA EPI mode ([@B17]).

GC-MS Analysis
--------------

GC--MS analysis was performed using an Agilent 6890 N Network GC System equipped with an Agilent 7683B Series auto-injector, coupled to an Agilent 5975 Inert Mass Selective Detector. The operating conditions were as follows: initial oven temperature, 50°C for 5 min, then to 150°C at 4°C/min and held for 5 min, then to 250°C at 4°C/min and held for 10 min; injector and detector temperatures, 275^o^C; injection volume, 0.2 μL; split ratio, 50:1. The carrier gas used was He at 1.0 mL/min. The significant MS operating parameters were: ionization voltage, 70 eV; ion source temperature 230^o^C; mass range 50--600 U ([@B1]).

GC-MS was performed for the *n*-hexane fraction of the ethanol extract of *C. aciculatus*. The constituents were identified by comparison of their mass spectra with reference spectra in the computer library (NIST 05).

Statistical Analysis
--------------------

All the results were expressesd as mean ± SEM. One-way and two-way ANOVA followed by Bonferroni's test was performed for statistical analysis. The results were considered significant when *p* \< 0.05. Graphpad Prism 5.03 software was used for conducting statistical analysis.

Computational Study
-------------------

Computational study of the identified compounds was conducted against human COX-2 enzyme, which is the inducible enzyme in human body contributing to inflammatory pain. Human COX-2 or Prostaglandin G/H Synthase 2 (PGH~2~) is a homo-dimer protein comprising 604 amino acids in each monomeric unit (UniProtKB ID: P35354). Homology model of the human COX-2 was built using Easy Modeler 4.0 taking three reported models as templates (PDB ID: 5F1A_A, 5IKQ_A, and 5F19_A) ([@B20]). The initial model was selected based on dope (Discrete Optimized Protein Energy) score and further validated by analyzing Ramachandran plot (Using procheck and rampage) ([@B22]; [@B25]). Knowledge based energy calculation was performed in ProSA ([@B43]). All the selected ligands were prepared using Autodock tools and the binding site in the enzyme was predicted through ProBiS server ([@B18]). Initial docking grid (40 × 40 × 40, 0.7 Å) enclosing the active binding site was generated depending on the binding of arachidonic acid. Finally all the prepared ligands were docked into the predicted binding pocket of the validated homology model of COX-2 utilizing Autodock Vina ([@B40]).

Results
=======

Results of Identification of Phytochemical Constituents
-------------------------------------------------------

Preliminary phytochemical investigation of the ethanol extract of *C. aciculatus* indicated the presence of tannins, terpenoids, alkaloids, flavonoids, saponins and glycosides.

Results of Acute Toxicity Test
------------------------------

In the acute toxicity study, no mortality was observed even at the highest doses of the extract. As per the Globally Harmonized Classification System (GHS) of chemicals, the crude extract of *C. aciculatus* can be categorized as category 5 or unclassified i.e., LD~50~ more than 5,000 mg/kg b.w. Conventionally, experimental doses should be ten times less than that of the toxic dose to avoid any interference of the toxicity in the observed pharmacological activity. Although no toxicity was observed in the acute toxicity study, test doses (500 and 750 mg/kg) in the present experiment were kept around ten times below the highest dose of acute toxicity test.

Results of Acetic Acid Induced Writhing Test
--------------------------------------------

Ethanol extract of *C. aciculatus* significantly (*p* \< 0.05) reduced the number of writings in the test mice at the both doses of 500 and 750 mg/kg tested (**Table [1](#T1){ref-type="table"}**). Both the results were comparable with diclofenac sodium (25 mg/kg) treated group, which showed the most potent analgesic activity.

###### 

Effect of *C. aciculatus* extract on acetic acid induced writhing in mice.

  Treatment Groups (*n* = 5)       Dose (mg/kg b.w.)   Number of writhing
  -------------------------------- ------------------- --------------------
  Control (1% Tween 80 in water)   10 ml/kg            31.2 ± 1.49
  Diclofenac sodium                25                  8.4 ± 0.51^∗∗^
  *C. aciculatus* extract          500                 20.2 ± 0.86^∗^
                                   750                 16.8 ± 1.07^∗∗^
                                                       

Values are represented as mean ± SEM,

∗

p

\< 0.05 vs. control,

∗∗

p

\< 0.005 vs. control.

Results of Hot Plate Test
-------------------------

In hot plate test, *C. aciculatus* extract displayed analgesic effect by increasing the response time in test mice at a dose and time dependent manner (**Table [2](#T2){ref-type="table"}**). The analgesic effect rose over time to the peak at 90 min and decreased afterwards. All the results were tested significant when compared to the standard morphine.

###### 

Effect of *C. aciculatus* extract in hot plate test in mice.

  Treatment Groups (*n* = 5)       Dose (mg/kg)   Reaction time (sec)                                                          
  -------------------------------- -------------- --------------------- ----------------- ----------------- ------------------ -----------------
  Control (1% Tween 80 in water)   10 ml/kg       4.20 ± 0.09           4.02 ± 0.165      4.01 ± 0.205      4.01 ± 0.201       4.02 ± 0.196
  Morphine                         25             4.24 ± 0.08           7.5 ± 0.15^∗∗^    12.6 ± 0.22^∗∗^   10.62 ± 0.18^∗∗^   8.31 ± 0.27^∗∗^
  *C. aciculatus* extract          500            4.12 ± 0.16           5.33 ± 0.28^∗^    6.72 ± 0.19^∗∗^   6.49 ± 0.23^∗∗^    5.23 ± 0.08^∗∗^
                                   750            4.37 ± 0.06           6.63 ± 0.20^∗∗^   7.72 ± 0.20^∗∗^   6.65 ± 0.29^∗∗^    5.44 ± 0.19^∗∗^
                                                                                                                               

Values are represented as mean ± SEM,

∗

p

\< 0.05 vs. control,

∗∗

p

\< 0.005 vs. control.

Results of LC-MS Analysis
-------------------------

The chemical constituents previously reported from *C. aciculatus* were matched with the molecular ion peaks observed in the recorded LC-MS (**Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}**). According to molecular weights three compounds were suggested as aciculatin, nudaphantin and 5α, 8α-epidioxyergosta-6, 22-diene-3β-ol or ergosterol peroxide having retention time of 34.859, 35.545, and 39.993 min, respectively (**Table [3](#T3){ref-type="table"}**). Another eight compounds from different plants belonging to the Poaceae family were also suggested to be present in *C. aciculatus* by analyzing the mass spectra (**Table [3](#T3){ref-type="table"}**).

###### 

Compounds identified in the ethanol extract of *C. aciculatus* using LC-MS.

                                       RT (min)   \[M + H\]^+^ experimental   Molecular formula        Molecular mass Calculated   Suggested compound                                                                                              Reference
  ------------------------------------ ---------- --------------------------- ------------------------ --------------------------- --------------------------------------------------------------------------------------------------------------- -----------
  From previously reported compounds   21.5       415.30                      C~22~H~22~O~8~           414.41                      Aciculatin                                                                                                      [@B21]
                                       21.7       391.28                      C~21~H~26~O~7~           390.432                     Nudaphantin                                                                                                     [@B39]
                                       29.3       429.37                      C~28~H~44~O~3~           428.657                     5α,8α-epidioxyergosta-6,22-diene-3β-ol/Ergosterol peroxide                                                      [@B14]
  From Poaceae family                  1.72       571.26                      C~30~H~18~O~12~          570.462                     Aurofusarin                                                                                                     [@B28]
                                       1.79       603.34                      C~40~H~58~O~4~           602.9                       Gamma-oryzanol                                                                                                  [@B26]
                                       2.17       317.18                      C~16~H~12~O~7~           316.265                     Isorhamnetin                                                                                                    [@B29]
                                       2.25       331.28                      C~17~H~14~O~7~           330.29                      Tricin                                                                                                          [@B8]
                                       31.54      279.15                      C~18~H~30~O~2~           278.436                     9,12,15-Octadecatrienoic acid                                                                                   [@B19]
                                       35.81      297.23                      C~12~H~12~N~2~O~3~S~2~   296.37                      *(\[(4-Oxo-3,5,6,7-tetrahydro-4*H*-cyclopenta\[4,5\]thieno\[2,3-*d*\]pyrimidin-2-yl)methyl\]thio)acetic acid*   [@B19]
                                       35.95      473.34                      C~31~H~52~O~3~           472.41                      Campesterol                                                                                                     [@B32]
                                       41.14      469.32                      C~32~H~52~O~2~           468.766                     Lupeol acetate                                                                                                  [@B41]
                                                                                                                                                                                                                                                   

Results of GC-MS Analysis
-------------------------

Gas chromatography of the *n*-hexane fraction of the test extract led to the elution of three compounds (**Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}**). Through searching the database for known fragmentation patterns, these three compounds were identified as citronellylisobutyrate (18.58%), 2,4-dihydroxy-7-methoxy-(2H)-1,4-benzoxazin-3(4H)-one (DIMBOA) (4.57%) and nudaphantin (76.85%) (**Table [4](#T4){ref-type="table"}**).

###### 

Chemical constituents identified in the *n*-hexane fraction of *C. aciculatus* extract by GC-MS.

  Peak no.   RT      %Area   %Height   A/H    Compound analyzed                                                Probable molecular weight   Probable molecular formula
  ---------- ------- ------- --------- ------ ---------------------------------------------------------------- --------------------------- ----------------------------
  **1.**     36.89   18.58   11.81     8.54   Citronellyl Isobutyrate                                          226                         C~14~H~26~O~2~
  **2.**     38.21   4.57    4.47      5.53   2,4-dihydroxy-7-methoxy-(2H)-1,4-benzoxazin-3(4H)-one (DIMBOA)   211.17                      C~9~H~9~NO~5~
  **3.**     53.94   76.85   83.72     4.98   Nudaphantin                                                      390.42                      C~21~H~26~O~7~
                                                                                                                                           

Results of Computational Study
==============================

The initial homology model of human COX-2 enzyme was selected based on the lowest dope profile and used for the docking (**Figure [1](#F1){ref-type="fig"}**). The sequence alignment is given in the **[Supplementary Materials](#SM1){ref-type="supplementary-material"}** (**Supplementary Figure [S3](#SM1){ref-type="supplementary-material"}**). The Ramachandran plot analysis showed that the number of residues in the favored, allowed and outlier regions are 97.8, 2.2, and 0.0%, respectively. In addition to the Z-score of -7.48 in knowledge base energy calculation, the low RMSD (root-mean-square deviation) of 0.8 to 0.9 Å between the overlaid model and template structure implied that the homology model was a theoretically reliable for molecular modeling study (**Supplementary Figure [S4](#SM1){ref-type="supplementary-material"}**). The homo-dimer model of COX-2 was generated from its monomeric units using GalaxyGemini following energy minimization step. The arachidonic acid binding pocket was identified with the following amino acid residues: Ala513, Val335, Gly512, Ser516, Tyr341, Phe343, Val102, Met99, Leu103, Val509, Leu338, Tyr371, and Ser339 (**Supplementary Figure [S5](#SM1){ref-type="supplementary-material"}**). Fourteen ligands obtained from the LC-MS and GC-MS analysis were docked into the active site of the human COX-2 homology model and nine different poses of the ligands in the binding site were analyzed (**Supplementary Figures [S6](#SM1){ref-type="supplementary-material"}**--**[S18](#SM1){ref-type="supplementary-material"}**) and the results are presented in **Table [5](#T5){ref-type="table"}**. Six ligands, namely citronellyl isobutyrate, octadeca 9,12,15-trienoic acid, (\[(4-oxo-3,5,6,7-tetrahydro-4Hcyclopenta\[4,5\] thieno \[2,3-d\]pyrimidin-2-yl)methyl\] thio) acetic acid, campesterol, gamma oryzanol and tricin were found to interact with some amino acid residues at the catalytic site with hydrophobic interactions. Eleven out of thirteen compounds showed higher affinity for COX-2 than that of arachidonic acid (-6.4 kcal/mol) with the highest affinity observed for aciculatin and aurofusarin (-9.2 and -11.7 kcal/mol).

![Homology model of Human COX-2 enzyme.](fphar-09-01164-g001){#F1}

###### 

Results of docking studies of the compounds identified in *C. aciculatus* extract on COX-2 enzyme.

  ------------------------------
  ![](fphar-09-01164-t005.jpg)
  ------------------------------

∗

Red colored texts indicate amino acid residues involved in the binding of arachidonic acid.

Discussion
==========

Acetic acid induced writhing reflex model in mice is a widely accepted and effective pain model for evaluating peripherally acting analgesics ([@B45]). In this method, acetic acid induces pain sensation via localized inflammatory response resulting from local release of arachidonic acid and subsequent prostaglandins through cyclooxygenase pathway of the arachidonate cascade ([@B7]). In other words, peritoneal administration of acetic acid raises the level of PGE~2~ and PGF~2α~ in the peritoneal fluid and causes inflammatory pain ([@B45]). In our study, ethanol extract of *C. aciculatus* significantly reduced the number of writhing in mice model and this decrease suggests that the test extract showed its analgesic activity through peripheral mechanism, which is the inhibition of prostaglandin biosynthesis by acting on visceral receptors sensitive to acetic acid ([@B36]). It is in agreement with the study reporting the presence of anti-inflammatory principle in this plant ([@B13]).

The hot plate method is a suitable assay for neurologic pain in evaluating centrally acting analgesics. This method measures a complex response to an acute and non-inflammatory nociception. Centrally acting analgesics like opioids usually act via supra spinal and spinal receptors; and therefore can increase the reaction time in hot plate test ([@B35]; [@B30]). Morphine, used as the standard drug in this test, is a renowned central analgesic that exerts its effect through binding with the opioid receptors (μ, κ, and δ) located in the post and pre synaptic membrane ([@B30]). It was demonstrated that oral administration of *C. aciculatus* extract prolonged the response latency period to heat stimulus in test mice that increased at higher dose. The effect was observable from 30 min of treatment and declined at the end of the observation period (**Table [2](#T2){ref-type="table"}**). As compared to the standard drug morphine, it can be suggested that the test extract has a mild central analgesic activity.

Results suggested that *C. aciculatus* has potential analgesic activity which is comparable to the standards, *i.e.*, diclofenac sodium and morphine, and showed significant difference from the control. In both bioassays the extract showed positive dose dependent effect confirming that this plant has both peripheral and central analgesic activity. As per the results obtained in preliminary phytochemical screening, the ethanolic extract of *C. aciculatus* contains several important phytoconstituent classes including flavonoids, tannins, and alkaloids. There are several reports available that demonstrate analgesic and anti-inflammatory activity of different compounds from the stated classes ([@B31]; [@B9]; [@B5]; [@B4]; [@B42]; [@B6]). We also identified a number of compounds in the test extract through LC-MS and GC-MS that were previously reported from this plant and the Poaceae famly. Among these compounds, the anti-inflammatory activity of aciculatin is well established. Aciculatin inhibits the expression of cyclooxygenase-2 (COX-2) by suppressing NF-κB and JNK/p38 MAPK activation pathways ([@B13]). COX-2 is the inducible isoenzyme in the arachidonate cascade that is responsible for inflammatory pain ([@B37]). Thus inhibition of its expression will lead to pain inhibition. Moreover, this plant contains quercetin and daucosterol ([@B14]). Quercetin acts as an analgesic both in neurogenic and inflammatory phases ([@B10]), whereas daucosterol reduces local inflammation ([@B27]). So, these constituents along with aciculatin can be held responsible for the observed antinociceptive activity of *C. aciculatus*.

Molecular docking studies with the identified ligands against human COX-2 enzyme revealed that, among the thirteen phytoconstituents, six compounds interacted with a number of amino acid residues (Ala513, Val335, Gly512, Ser516, Tyr341, Phe343, Val102, Met99, Leu103, Val509, Leu338, Tyr371, Ser339) associated with the binding of arachidonic acid at the catalytic site, with binding affinity ranging between -6.2 and -8.4 kcal/mol. Among these six compounds, tricin, an *O*-methylated flavone, showed lower binding affinity (-8.2 kcal/mol) than that of aciculatin and aurofusarin, but with greater number (12) of interaction with the amino acid residues involved in the binding of arachidonic acid through hydrophobic interactions. Campesterol interacted with Leu338, Gly512, Met99, Val509, Leu103, Ser516, Tyr341, Phe343, Ala513 and Tyr371 with an affinity of -8.4 kcal/mol. Gamma oryzanol also interacted with 10 amino acid residues with an affinity of -7.3 kcal/mol. 9, 12, 15-octadecatrienoic acid (Binding affinity: -6.2 kcal/mol) and citronellyl isobutyrate (Binding affinity: -6.4 kcal/mol) showed interaction with nine and eight amino acid residues, respectively. The other seven compounds also showed some affinity for COX-2 enzyme but the amino acid residues were not involved in the binding of arachidonic acid. So the conclusion can be drawn from these results that, these identified secondary metabolites may have some part in the observed analgesic activity of this plant extract.

Conclusion
==========

Results from the present study confirmed that *C. aciculatus* possesses significant and dose dependent analgesic activity, which supports the uses of the plant in folk medicine. This activity may be attributed to aciculatin, an anti-inflammatory glycosylflavone, identified in the plant and the identified phytoconstituents showing promising affinity toward human COX-2 enzyme in computational study.
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